DECISION NO. 1282, DATED 27.03.2026

ON THE AUTHORIZATION OF THE PROPOSED CONCENTRATION FOR THE ACQUISITION OF INDIRECT CONTROL OF Swixx Biopharma Holding AG BY SK Capital Partners, LP THROUGH SKES Investment 17 S.à r.l.

Skip to content